Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II study of IMO-8400 in dermatomyositis does not meet primary endpoint

June 13, 2018

Tyme reports detailed data from first-in-human study and compassionate use program of SM-88

June 13, 2018

Recommended phase II dose established in first-in-human study of 2X-121

June 13, 2018

FDA awards fast track designation to RGX-111 for MPS I

June 13, 2018

Japanese authorities grant priority review to lorlatinib application

June 13, 2018

ProQR Therapeutics enters partnership to advance development of QR-313

June 13, 2018

Senhwa Biosciences and PBTC to study CX-4945 in pediatric recurrent medulloblastoma

June 13, 2018

Herantis initiates phase II study of Lymfactin for secondary lymphedema

June 13, 2018

Galmed reports 1-year data from phase IIb study of Aramchol in NASH

June 13, 2018

E-Scape Bio obtains rights to S1P5 receptor agonists from AbbVie for lysosomal storage disorders

June 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...